South Korean bio firms, including Samsung Biologics and Lotte Biologics, fiercely competed for orders at BioJapan 2025, highlighting advanced CDMO capabilities and attracting global investor interest.
#YonhapInfomax
#BioJapan2025 #SamsungBiologics #LotteBiologics #CDMO #InvestorInterest
#Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=84824
#YonhapInfomax
#BioJapan2025 #SamsungBiologics #LotteBiologics #CDMO #InvestorInterest
#Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=84824
'From Dedicated Booths to Technical Experts'—Fierce Competition Among K-Bio Firms for Orders in Japan
South Korean bio firms, including Samsung Biologics and Lotte Biologics, fiercely competed for orders at BioJapan 2025, highlighting advanced CDMO capabilities and attracting global investor interest.